HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM은(는) 2023년 6월 14일에 상장 폐지됐어요.
소개: HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
직원 수: 54
뉴스
HTGM에 대한 최신 뉴스 기사를 아직 받지 못했어요.